Lower insulin and glucose spikes
Use as directed: For adults, take one (1) quick release capsule one to two times daily, preferably on an empty stomach
Both are FDA-approved, both have solid research behind them, and both can help you reach your health goals
Your SheMed clinician will guide this decision based on your progress and how well you are tolerating the current dose
Retatrutide, a GIP/GLP-1/Glucagon receptor agonist (GGG tri-agonist) in development by Eli Lilly and Company, isnt on the market yet
"Making affordable, holistic obesity treatment accessible has the potential to help strengthen the local healthcare system and unlock the potential for millions of Canadians to live healthier, more fulfilling lives." There is currently no generic version of semaglutide approved by the Canadian health agency for sale, but the approval process for companies is underway